Analysis depression
Analysis suppression can be described as a distinct decrease in one's overall ability to process information and logically or creatively analyze concepts, ideas, and scenarios. The experience of this effect leads to significant difficulty contemplating or understanding basic ideas in a manner which can temporarily prevent normal cognitive functioning.
Analysis suppression is often accompanied by other coinciding effects such as sedation, thought deceleration, and emotion suppression. It is most commonly induced under the influence of moderate dosages of antipsychotic compounds, such as quetiapine, haloperidol, and risperidone. However, it can also occur in a less consistent form under the influence of heavy dosages of dissociatives, cannabinoids, and GABAergic depressants.
Psychoactive substances
Compounds within our psychoactive substance index which may cause this effect include:
- 1,4-Butanediol
- 2M2B
- 3-MeO-PCE
- 3-MeO-PCMo
- 4-MeO-PCP
- 5F-AKB48
- 5F-PB-22
- AB-FUBINACA
- APICA
- Alcohol
- Alprazolam
- Amanita muscaria
- Baclofen
- Barbiturates
- Benzodiazepines
- Bromazepam
- Cannabis
- Carisoprodol
- Clonazepam
- Clonazolam
- DOB
- Deschloroetizolam
- Deschloroketamine
- Dextromethorphan
- Diazepam
- Diclazepam
- Diphenhydramine
- Diphenidine
- Ephenidine
- Eszopiclone
- Etizolam
- F-Phenibut
- Flualprazolam
- Flubromazepam
- Flubromazolam
- Flunitrazepam
- Flunitrazolam
- GBL
- GHB
- Gabapentin
- Gaboxadol
- HXE
- JWH-018
- JWH-073
- Ketamine
- Lorazepam
- Memantine
- Methaqualone
- Methoxetamine
- Methoxphenidine